Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Per 10Q, overtime was the issue. Well, the real issue is high demand, a good problem to have. New facility will drive efficiency and margins above where we have historically been. 

"Our gross profit margin was 43% during the three months ended September 30, 2024 as compared to 46% during the comparable period of the prior fiscal year. The decrease is due to increased labor costs resulting from manufacturing personnel overtime hours incurred to ensure production and supply of our products in response to increased demand."